APIP Human

APAF1 interacting protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Methionine Salvage Pathway

APIP functions as methylthioribulose-1-phosphate dehydratase (MtnB), catalyzing:
MTRu-1-PDK-MTP-1-P\text{MTRu-1-P} \rightarrow \text{DK-MTP-1-P}

  • Kinetic parameters: Km=9.32 μM,Vmax=1.39 μmol min1 mg1K_m = 9.32\ \mu\text{M}, V_{\text{max}} = 1.39\ \mu\text{mol}\ \text{min}^{-1}\ \text{mg}^{-1} .

  • Essential for cell viability under methionine-restricted conditions (e.g., MTA supplementation) .

Cell Death Inhibition

APIP independently regulates two forms of programmed cell death:

  • Apoptosis: Binds Apaf-1 to block cytochrome c-mediated caspase activation .

  • Pyroptosis: Requires MtnB enzymatic activity to reduce intracellular MTA levels, which exacerbate pyroptosis .

FunctionMechanismDependency on MtnB Activity
Apoptosis inhibitionApaf-1 interactionIndependent
Pyroptosis inhibitionMTA metabolism regulationDependent
Data from .

Genetic and Pharmacological Insights

  • APIP knockdown reduces cell growth in MTA-dependent conditions by 70% .

  • C97A mutation abolishes catalytic activity, causing dominant-negative effects in methionine salvage .

  • Overexpression reduces intracellular MTA by 40%, mitigating pyroptosis .

Clinical and Therapeutic Relevance

APIP’s dual roles link it to:

  • Cancer: Methionine dependency in tumors makes APIP a potential metabolic target .

  • Inflammatory diseases: Pyroptosis regulation via MTA modulation could treat sepsis or autoimmunity .

  • Ischemic injury: APIP overexpression protects against muscle ischemic damage .

Recombinant APIP Production

The human recombinant protein (e.g., PRO-1186) is expressed in E. coli with an N-terminal His-tag, enabling studies on enzymatic and anti-apoptotic activities .

Applications:

  • In vitro enzyme kinetics assays.

  • Screening for inhibitors targeting APIP’s catalytic or Apaf-1-binding domains.

Product Specs

Introduction
APIP, an enzyme, plays a crucial role in the methionine salvage pathway by catalyzing the conversion of methylthioribulose-1-phosphate (MTRu-1-P) to 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P). Beyond its enzymatic function, APIP exhibits anti-apoptotic properties, protecting cells from programmed death by inhibiting both cytochrome c-dependent and APAF1-mediated pathways. This protective effect has been linked to reduced muscle damage following ischemia.
Description
This product consists of the recombinant human APIP protein, expressed in E. coli and purified to a high degree. The protein encompasses amino acids 1 to 242 of the APIP sequence, with an additional 24-amino acid His-tag fused at the N-terminus. The molecular weight of the tagged protein is 29.7kDa. Purification is achieved through proprietary chromatographic methods.
Physical Appearance
The product is a clear, colorless solution that has been sterilized by filtration.
Formulation
The APIP protein is provided at a concentration of 0.5mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 1mM DTT, and 20% glycerol.
Stability
For short-term storage (up to 4 weeks), the product can be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To further enhance stability during long-term storage, the addition of a carrier protein like HSA or BSA to a final concentration of 0.1% is advisable. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of the APIP protein in this product is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
APAF1 interacting protein, CGI-29, APIP2, Mmrp19, APAF1-interacting protein, MTRu-1-P dehydratase, probable methylthioribulose-1-phosphate dehydratase, CGI29, EC 4.2.1.109, dJ179L10.2, MMRP19.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMSGCDA REGDCCSRRC GAQDKEHPRY LIPELCKQFY HLGWVTGTGG GISLKHGDEI YIAPSGVQKE RIQPEDMFVC DINEKDISGP SPSKKLKKSQ CTPLFMNAYT MRGAGAVIHT HSKAAVMATL LFPGREFKIT HQEMIKGIKK CTSGGYYRYD DMLVVPIIEN TPEEKDLKDR MAHAMNEYPD SCAVLVRRHG VYVWGETWEK AKTMCECYDY LFDIAVSMKK VGLDPSQLPV GENGIV

Q&A

What is APIP and what are its primary research applications?

APIP (Apaf-1 Interacting Protein) is a human gene that can be targeted for genetic manipulation studies. Current research applications include using CRISPR/Cas9-based systems with a deactivated Cas9 (dCas9) nuclease fused to a VP64 activation domain for gene upregulation. This approach employs target-specific sgRNA engineered to bind the MS2-P65 to create a robust transcription activation system specifically for human APIP . This methodology allows researchers to investigate APIP's functional role by selectively increasing its expression in experimental systems.

What methodological approaches are most effective for studying APIP expression?

When investigating APIP expression, researchers should implement a multi-faceted approach that includes both traditional and advanced methodologies. Lentiviral activation particles offer a powerful tool for APIP upregulation studies, utilizing the CRISPR/Cas9 system's precision . For comprehensive expression analysis, researchers should consider employing Bayesian optimal experimental design (BOED) principles, which formalize the search for optimal experimental designs by identifying experiments expected to yield the most informative data . This approach requires researchers to specify all controllable parameters of their experiment and then determine optimal settings by maximizing a utility function aligned with their specific research questions.

How should researchers approach contradictory findings in APIP studies?

Conflicting results in APIP research require systematic resolution strategies. Researchers should formalize competing hypotheses as computational models and design experiments specifically aimed at discriminating between these models. The Bayesian optimal experimental design (BOED) framework offers a principled approach by rephrasing the task of finding optimal experimental designs as solving an optimization problem . When faced with contradictory data, researchers should carefully examine differences in experimental conditions, consider cell type-specific effects, evaluate statistical power in existing studies, and potentially conduct meta-analyses when sufficient data is available.

How can machine learning optimize experimental design for APIP studies?

Machine learning approaches offer significant advantages for optimizing APIP research. A flexible workflow combining recent advances in ML and BOED can optimize experimental designs for any computational model from which researchers can simulate data . For APIP studies, this methodology allows researchers to:

  • Define clear scientific goals (e.g., model discrimination or parameter estimation)

  • Formalize theories as computational models that can be sampled from

  • Determine which aspects of the experimental design need optimization

  • Construct required ML models and train them with simulated data

  • Validate obtained optimal designs before performing actual experiments

This approach has been shown to yield significantly better model recovery, more informative posterior distributions, and improved parameter disentanglement compared to commonly used experimental designs .

What control conditions are essential when using lentiviral activation particles for APIP studies?

When using APIP Lentiviral Activation Particles for gene upregulation studies, researchers must implement several critical controls:

Control TypePurposeImplementation
Negative ControlsAccount for non-specific effectsNon-targeting constructs with identical backbone
Positive ControlsValidate system functionalityKnown target genes with established responses
Dose-Response ControlsEstablish expression-phenotype relationshipMultiple MOI levels of APIP activation particles
Temporal ControlsDistinguish primary from secondary effectsTime-course measurements after transduction
Cell Type ControlsIdentify context-dependent effectsParallel experiments in multiple relevant cell lines

Proper implementation of these controls is essential for valid interpretation of APIP manipulation experiments and helps researchers distinguish direct effects from experimental artifacts .

How should researchers design experiments to investigate APIP's role in specific cellular pathways?

Investigating APIP's role in cellular pathways requires thoughtful experimental design. Researchers should utilize the workflow outlined in Bayesian optimal experimental design, which comprises defining a scientific goal, formalizing theories as computational models, setting up the design optimization problem, constructing ML models, and validating designs in silico . For pathway analysis specifically, researchers should:

  • Develop computational models representing hypothesized APIP pathway interactions

  • Identify which experimental parameters (e.g., stimulation conditions, measurement timepoints) should be optimized

  • Generate simulated datasets under different parameter settings

  • Train ML models to predict which experimental designs will yield maximum information

  • Validate optimal designs through simulation before proceeding to wet-lab experiments

This systematic approach maximizes the information gained from each experiment while minimizing resource expenditure.

How can researchers leverage health data networks for APIP translational research?

Translational APIP research can benefit significantly from health data networks that combine consumer-permission health data with digital capabilities. LexisNexis® Human API™ provides access to over 30,000 data connections including medical records, labs, and fitness wearables . For APIP researchers, this offers opportunities to:

  • Examine correlations between APIP variants and clinical outcomes across diverse populations

  • Identify potential phenotypic manifestations of APIP dysregulation in real-world settings

  • Discover novel research questions by analyzing patterns in large health datasets

  • Validate laboratory findings against clinical observations

  • Recruit specific patient populations for interventional studies

When utilizing these resources, researchers must ensure proper consent protocols, develop clear data management plans, and implement robust data harmonization protocols .

What statistical approaches are most appropriate for analyzing complex APIP experimental data?

Analysis of complex APIP experimental data requires sophisticated statistical approaches. Bayesian methods offer particular advantages, as they allow integration of prior knowledge with new experimental results . For optimal statistical analysis, researchers should:

  • Address distributional properties of expression data, which is often non-normal

  • Account for batch effects and technical variability through appropriate normalization

  • Implement multiple testing corrections when performing genome-wide analyses

  • Consider mixed-effects models for complex experimental designs

  • Use simulation studies to compare performance of different statistical methods

  • Apply regularization techniques when dealing with high-dimensional data

  • Consider amortized posterior inference techniques, which allow researchers to easily compute posterior distributions that might otherwise be computationally expensive

These approaches help ensure robust, reproducible findings from APIP manipulation experiments.

How can researchers integrate multi-omics data in APIP studies?

Integrating multi-omics data presents significant challenges but offers comprehensive insights into APIP function. Researchers can leverage machine learning approaches similar to those used in optimal experimental design , developing integrated computational models that can be tested against multi-omics datasets. Key integration strategies include:

Data TypeIntegration ChallengeSolution Approach
TranscriptomicsTemporal dynamics differ from proteomicsTime-course modeling with appropriate lags
ProteomicsPost-translational modificationsSpecialized detection methods combined with RNA data
MetabolomicsIndirect relationship to gene expressionPathway-based integration models
EpigenomicsCell-type specificitySingle-cell approaches with computational deconvolution
Clinical DataHeterogeneous measurement practicesStandardization through medical ontologies

By implementing these strategies, researchers can develop a comprehensive understanding of APIP's biological role across multiple molecular levels.

What are the most common pitfalls in APIP upregulation experiments and how can they be avoided?

APIP upregulation experiments using lentiviral activation particles can encounter several challenges. Common pitfalls and their solutions include:

  • Low Transduction Efficiency: Optimize cell-specific transduction protocols and consider using transduction enhancers for difficult cell types.

  • Off-Target Effects: Thoroughly validate sgRNA specificity and include appropriate control conditions to distinguish specific from non-specific effects.

  • Variable Expression Levels: Implement single-cell analyses to account for heterogeneity in APIP upregulation.

  • Compensatory Mechanisms: Design time-course experiments to capture immediate responses before compensation occurs.

  • Cytotoxicity: Titrate lentiviral particles carefully and monitor cell viability throughout the experiment.

By anticipating these challenges, researchers can design more robust experiments that yield reliable and interpretable results .

How should researchers validate APIP upregulation in experimental systems?

Validation of APIP upregulation requires multiple complementary approaches to ensure robust results. Researchers should implement:

  • mRNA Quantification: RT-qPCR with appropriate reference genes for normalization

  • Protein Detection: Western blotting or mass spectrometry to confirm translation

  • Functional Assays: Phenotypic assays specific to hypothesized APIP functions

  • Single-Cell Analysis: Flow cytometry or single-cell RNA-seq to assess population heterogeneity

  • Time-Course Studies: Temporal profiling to determine stability of upregulation

When designing validation experiments, researchers should apply optimal experimental design principles to ensure the most informative measurement timepoints and conditions .

How can researchers distinguish direct from indirect effects of APIP manipulation?

Distinguishing direct from indirect effects of APIP manipulation presents a significant methodological challenge. Researchers should implement a systematic approach that includes:

  • Performing time-course experiments to identify immediate versus delayed responses

  • Using inducible expression systems for temporal control of APIP upregulation

  • Implementing rescue experiments with mutated APIP variants to identify functional domains

  • Conducting protein-protein interaction studies to identify direct binding partners

  • Applying causal inference statistical methods to observational data

  • Designing optimal experiments specifically aimed at discriminating between direct and indirect effect models

By combining these approaches, researchers can build a more accurate model of APIP's direct functional roles versus downstream effects.

Product Science Overview

Structure and Function

APAF1 contains several important domains:

  • WD-40 repeats: These are involved in protein-protein interactions.
  • Caspase Recruitment Domain (CARD): This domain is essential for the interaction with procaspase-9.
  • ATPase domain (NB-ARC): This domain is involved in the oligomerization of APAF1.

Upon binding to cytochrome c and dATP, APAF1 undergoes a conformational change that allows it to oligomerize and form the apoptosome, a large quaternary protein structure. The apoptosome then recruits and activates procaspase-9, which in turn activates the executioner caspases, leading to apoptosis .

APAF1 Interacting Protein

The APAF1 interacting protein (Human Recombinant) is a synthetic version of the naturally occurring protein that interacts with APAF1. This interaction is crucial for the formation and function of the apoptosome. The recombinant version is produced using recombinant DNA technology, which involves inserting the gene encoding the APAF1 interacting protein into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities.

Biological Significance

The interaction between APAF1 and its interacting proteins is vital for the regulation of apoptosis. Dysregulation of apoptosis can lead to various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, understanding the interactions of APAF1 is crucial for developing therapeutic strategies for these conditions .

Research and Applications

Recombinant APAF1 interacting protein is widely used in research to study the mechanisms of apoptosis. It is also used in drug discovery and development, as targeting the apoptotic pathway is a promising strategy for treating diseases characterized by either excessive or insufficient apoptosis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.